US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 11.200
  • -0.250-2.18%
Close Mar 28 16:00 ET
  • 11.200
  • 0.0000.00%
Post 20:01 ET
516.26MMarket Cap-3.78P/E (TTM)

UroGen Pharma Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
72.80%236.69M
72.80%236.69M
69.30%249.58M
409.67%241.08M
152.17%164.05M
37.02%136.97M
37.02%136.97M
53.70%147.42M
-57.67%47.3M
-52.32%65.05M
-Cash and cash equivalents
81.04%171.99M
81.04%171.99M
4.70%124.92M
992.92%219.97M
259.71%131.44M
71.46%95M
71.46%95M
315.90%119.31M
-75.06%20.13M
-65.33%36.54M
-Short-term investments
54.17%64.7M
54.17%64.7M
343.41%124.66M
-22.33%21.11M
14.35%32.61M
-5.81%41.97M
-5.81%41.97M
-58.18%28.11M
-12.48%27.17M
-8.21%28.51M
Receivables
31.46%20.3M
31.46%20.3M
77.49%22.8M
12.32%17.42M
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
-Accounts receivable
31.46%20.3M
31.46%20.3M
77.49%22.8M
12.32%17.42M
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
Inventory
62.65%9.23M
62.65%9.23M
51.82%7.59M
49.20%7.44M
32.51%7.24M
31.17%5.67M
31.17%5.67M
2.88%5M
-1.17%4.99M
14.93%5.47M
Restricted cash
31.06%1.08M
31.06%1.08M
31.33%1.07M
1.10%825K
1.11%823K
0.98%821K
0.98%821K
0.62%817K
0.62%816K
48.00%814K
Other current assets
-13.97%8.85M
-13.97%8.85M
-12.38%14.05M
-4.05%12.21M
-13.63%10.49M
-7.39%10.28M
-7.39%10.28M
51.59%16.04M
21.95%12.72M
30.95%12.15M
Total current assets
63.21%276.14M
63.21%276.14M
62.03%295.1M
242.99%278.97M
105.02%196.76M
31.25%169.19M
31.25%169.19M
49.78%182.12M
-41.75%81.33M
-40.21%95.97M
Non current assets
Net PPE
60.55%3.79M
60.55%3.79M
-39.15%1.66M
-39.34%1.83M
-41.46%2.01M
-37.05%2.36M
-37.05%2.36M
-34.81%2.73M
-18.92%3.02M
26.08%3.43M
-Gross PPE
27.85%8.07M
27.85%8.07M
-9.51%5.87M
-9.36%5.98M
-10.52%6.08M
-8.51%6.31M
-8.51%6.31M
-8.58%6.49M
3.06%6.59M
31.69%6.8M
-Accumulated depreciation
-8.32%-4.28M
-8.32%-4.28M
-11.99%-4.21M
-15.94%-4.15M
-21.03%-4.08M
-25.46%-3.95M
-25.46%-3.95M
-29.10%-3.76M
-33.64%-3.58M
-37.94%-3.37M
Investments and advances
11.55%5.02M
11.55%5.02M
-28.68%4.64M
-97.45%203K
-95.27%481K
--4.5M
--4.5M
--6.51M
1,084.25%7.97M
1,408.16%10.17M
Other non current assets
-66.20%765K
-66.20%765K
-76.04%545K
-72.11%848K
-60.87%1.32M
-23.62%2.26M
-23.62%2.26M
-15.55%2.28M
43.24%3.04M
88.52%3.38M
Total non current assets
4.94%9.58M
4.94%9.58M
-40.52%6.85M
-79.46%2.88M
-77.54%3.81M
35.95%9.13M
35.95%9.13M
67.32%11.51M
115.25%14.03M
227.12%16.98M
Total assets
60.23%285.71M
60.23%285.71M
55.94%301.94M
195.56%281.85M
77.57%200.57M
31.48%178.31M
31.48%178.31M
50.72%193.63M
-34.75%95.36M
-31.84%112.95M
Liabilities
Current liabilities
Payables
67.81%10.93M
67.81%10.93M
37.49%5.56M
78.51%8.32M
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-accounts payable
67.81%10.93M
67.81%10.93M
37.49%5.56M
78.51%8.32M
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
Current accrued expenses
64.60%16.5M
64.60%16.5M
40.70%14.13M
31.45%15.44M
17.09%11.9M
46.21%10.02M
46.21%10.02M
47.44%10.04M
89.73%11.74M
78.22%10.16M
Other current liabilities
105.91%7.95M
105.91%7.95M
14.64%4.07M
-0.58%3.62M
0.38%3.2M
17.83%3.86M
17.83%3.86M
17.73%3.55M
22.80%3.64M
-20.55%3.19M
Current liabilities
47.22%45.95M
47.22%45.95M
27.14%32.79M
27.86%34.22M
4.38%26.34M
30.51%31.21M
30.51%31.21M
35.73%25.79M
48.36%26.77M
32.18%25.23M
Non current liabilities
Long term debt and capital lease obligation
24.14%123.39M
24.14%123.39M
22.48%121.92M
-1.27%98.24M
-1.12%98.23M
0.27%99.4M
0.27%99.4M
35.02%99.54M
36.85%99.51M
39.78%99.34M
-Long term debt
23.52%121.73M
23.52%121.73M
23.54%121.71M
-0.49%97.81M
-0.36%97.59M
1.04%98.55M
1.04%98.55M
37.08%98.52M
38.06%98.3M
38.34%97.94M
-Long term capital lease obligation
95.85%1.65M
95.85%1.65M
-79.34%212K
-64.85%425K
-54.60%637K
-46.78%844K
-46.78%844K
-44.72%1.03M
-20.20%1.21M
406.50%1.4M
Derivative product liabilities
10.63%121.39M
10.63%121.39M
10.49%118.53M
10.88%115.88M
10.83%112.95M
10.92%109.72M
10.92%109.72M
11.52%107.28M
11.82%104.51M
13.51%101.91M
Total non current liabilities
17.08%248.57M
17.08%248.57M
16.11%243.64M
4.97%217.31M
4.94%214.37M
5.59%212.31M
5.59%212.31M
21.46%209.84M
22.49%207.03M
24.79%204.27M
Total liabilities
20.94%294.51M
20.94%294.51M
17.32%276.43M
7.59%251.54M
4.88%240.71M
8.24%243.52M
8.24%243.52M
22.88%235.63M
24.99%233.8M
25.56%229.51M
Shareholders'equity
Share capital
29.21%115K
29.21%115K
36.90%115K
75.00%112K
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
-common stock
29.21%115K
29.21%115K
36.90%115K
75.00%112K
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
Retained earnings
-18.68%-806.22M
-18.68%-806.22M
-17.66%-768.71M
-17.99%-745.04M
-17.18%-711.63M
-17.72%-679.35M
-17.72%-679.35M
-19.17%-653.33M
-20.87%-631.45M
-22.51%-607.32M
Paid-in capital
29.84%797.25M
29.84%797.25M
29.85%793.87M
57.22%775.27M
36.82%671.44M
25.88%614.04M
25.88%614.04M
26.05%611.39M
2.41%493.11M
2.53%490.74M
Gains losses not affecting retained earnings
366.67%56K
366.67%56K
276.12%236K
79.87%-31K
17.78%-37K
111.21%12K
111.21%12K
13.55%-134K
-175.00%-154K
34.78%-45K
Total stockholders'equity
86.50%-8.8M
86.50%-8.8M
160.76%25.52M
121.90%30.31M
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
Total equity
86.50%-8.8M
86.50%-8.8M
160.76%25.52M
121.90%30.31M
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 72.80%236.69M72.80%236.69M69.30%249.58M409.67%241.08M152.17%164.05M37.02%136.97M37.02%136.97M53.70%147.42M-57.67%47.3M-52.32%65.05M
-Cash and cash equivalents 81.04%171.99M81.04%171.99M4.70%124.92M992.92%219.97M259.71%131.44M71.46%95M71.46%95M315.90%119.31M-75.06%20.13M-65.33%36.54M
-Short-term investments 54.17%64.7M54.17%64.7M343.41%124.66M-22.33%21.11M14.35%32.61M-5.81%41.97M-5.81%41.97M-58.18%28.11M-12.48%27.17M-8.21%28.51M
Receivables 31.46%20.3M31.46%20.3M77.49%22.8M12.32%17.42M13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M
-Accounts receivable 31.46%20.3M31.46%20.3M77.49%22.8M12.32%17.42M13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M
Inventory 62.65%9.23M62.65%9.23M51.82%7.59M49.20%7.44M32.51%7.24M31.17%5.67M31.17%5.67M2.88%5M-1.17%4.99M14.93%5.47M
Restricted cash 31.06%1.08M31.06%1.08M31.33%1.07M1.10%825K1.11%823K0.98%821K0.98%821K0.62%817K0.62%816K48.00%814K
Other current assets -13.97%8.85M-13.97%8.85M-12.38%14.05M-4.05%12.21M-13.63%10.49M-7.39%10.28M-7.39%10.28M51.59%16.04M21.95%12.72M30.95%12.15M
Total current assets 63.21%276.14M63.21%276.14M62.03%295.1M242.99%278.97M105.02%196.76M31.25%169.19M31.25%169.19M49.78%182.12M-41.75%81.33M-40.21%95.97M
Non current assets
Net PPE 60.55%3.79M60.55%3.79M-39.15%1.66M-39.34%1.83M-41.46%2.01M-37.05%2.36M-37.05%2.36M-34.81%2.73M-18.92%3.02M26.08%3.43M
-Gross PPE 27.85%8.07M27.85%8.07M-9.51%5.87M-9.36%5.98M-10.52%6.08M-8.51%6.31M-8.51%6.31M-8.58%6.49M3.06%6.59M31.69%6.8M
-Accumulated depreciation -8.32%-4.28M-8.32%-4.28M-11.99%-4.21M-15.94%-4.15M-21.03%-4.08M-25.46%-3.95M-25.46%-3.95M-29.10%-3.76M-33.64%-3.58M-37.94%-3.37M
Investments and advances 11.55%5.02M11.55%5.02M-28.68%4.64M-97.45%203K-95.27%481K--4.5M--4.5M--6.51M1,084.25%7.97M1,408.16%10.17M
Other non current assets -66.20%765K-66.20%765K-76.04%545K-72.11%848K-60.87%1.32M-23.62%2.26M-23.62%2.26M-15.55%2.28M43.24%3.04M88.52%3.38M
Total non current assets 4.94%9.58M4.94%9.58M-40.52%6.85M-79.46%2.88M-77.54%3.81M35.95%9.13M35.95%9.13M67.32%11.51M115.25%14.03M227.12%16.98M
Total assets 60.23%285.71M60.23%285.71M55.94%301.94M195.56%281.85M77.57%200.57M31.48%178.31M31.48%178.31M50.72%193.63M-34.75%95.36M-31.84%112.95M
Liabilities
Current liabilities
Payables 67.81%10.93M67.81%10.93M37.49%5.56M78.51%8.32M-10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M
-accounts payable 67.81%10.93M67.81%10.93M37.49%5.56M78.51%8.32M-10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M
Current accrued expenses 64.60%16.5M64.60%16.5M40.70%14.13M31.45%15.44M17.09%11.9M46.21%10.02M46.21%10.02M47.44%10.04M89.73%11.74M78.22%10.16M
Other current liabilities 105.91%7.95M105.91%7.95M14.64%4.07M-0.58%3.62M0.38%3.2M17.83%3.86M17.83%3.86M17.73%3.55M22.80%3.64M-20.55%3.19M
Current liabilities 47.22%45.95M47.22%45.95M27.14%32.79M27.86%34.22M4.38%26.34M30.51%31.21M30.51%31.21M35.73%25.79M48.36%26.77M32.18%25.23M
Non current liabilities
Long term debt and capital lease obligation 24.14%123.39M24.14%123.39M22.48%121.92M-1.27%98.24M-1.12%98.23M0.27%99.4M0.27%99.4M35.02%99.54M36.85%99.51M39.78%99.34M
-Long term debt 23.52%121.73M23.52%121.73M23.54%121.71M-0.49%97.81M-0.36%97.59M1.04%98.55M1.04%98.55M37.08%98.52M38.06%98.3M38.34%97.94M
-Long term capital lease obligation 95.85%1.65M95.85%1.65M-79.34%212K-64.85%425K-54.60%637K-46.78%844K-46.78%844K-44.72%1.03M-20.20%1.21M406.50%1.4M
Derivative product liabilities 10.63%121.39M10.63%121.39M10.49%118.53M10.88%115.88M10.83%112.95M10.92%109.72M10.92%109.72M11.52%107.28M11.82%104.51M13.51%101.91M
Total non current liabilities 17.08%248.57M17.08%248.57M16.11%243.64M4.97%217.31M4.94%214.37M5.59%212.31M5.59%212.31M21.46%209.84M22.49%207.03M24.79%204.27M
Total liabilities 20.94%294.51M20.94%294.51M17.32%276.43M7.59%251.54M4.88%240.71M8.24%243.52M8.24%243.52M22.88%235.63M24.99%233.8M25.56%229.51M
Shareholders'equity
Share capital 29.21%115K29.21%115K36.90%115K75.00%112K54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K
-common stock 29.21%115K29.21%115K36.90%115K75.00%112K54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K
Retained earnings -18.68%-806.22M-18.68%-806.22M-17.66%-768.71M-17.99%-745.04M-17.18%-711.63M-17.72%-679.35M-17.72%-679.35M-19.17%-653.33M-20.87%-631.45M-22.51%-607.32M
Paid-in capital 29.84%797.25M29.84%797.25M29.85%793.87M57.22%775.27M36.82%671.44M25.88%614.04M25.88%614.04M26.05%611.39M2.41%493.11M2.53%490.74M
Gains losses not affecting retained earnings 366.67%56K366.67%56K276.12%236K79.87%-31K17.78%-37K111.21%12K111.21%12K13.55%-134K-175.00%-154K34.78%-45K
Total stockholders'equity 86.50%-8.8M86.50%-8.8M160.76%25.52M121.90%30.31M65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M
Total equity 86.50%-8.8M86.50%-8.8M160.76%25.52M121.90%30.31M65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More